Results 11 to 20 of about 92,434 (342)

Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome

Frontiers in Immunology, 2022
BackgroundInterstitial lung disease (ILD) is frequently observed in anti-melanoma differentiation-associated protein 5 (MDA5) antibody positive dermatomyositis (DM) and anti-synthetase syndrome (ASS), where they often develop a rapidly progressive ILD ...
Yu Zuo, Lifang Ye, Lifang Ye, Fang Chen, Yawen Shen, Xin Lu, Guochun Wang, Guochun Wang, Xiaoming Shu   +8 more
doaj   +1 more source

COVID-19 vaccine-associated myositis: a comprehensive review of the literature driven by a case report

Immunologic research, 2023
Several cases of vaccine-associated manifestations have been published including cases of inflammatory myositis. Herein, we comprehensively review the literature on the occasion of case of a woman with inflammatory myositis following COVID-19 vaccination.
Vasiliki Syrmou, C. Liaskos, N. Ntavari, K. Mitsimponas, T. Simopoulou, I. Alexiou, M. Vlychou, C. Katsiari, D. Bogdanos   +8 more
semanticscholar   +1 more source

Adrenomedullin Expression Is Associated With the Severity and Poor Prognosis of Interstitial Lung Disease in Dermatomyositis Patients

Frontiers in Immunology, 2022
ObjectiveTo evaluate adrenomedullin mRNA levels in the peripheral blood mononuclear cells (PBMCs) of patients with dermatomyositis (DM) as well as their correlation with the severity of interstitial lung disease (ILD).MethodsA total of 41 DM patients and
Lifang Ye, Lifang Ye, Yu Zuo, Fang Chen, Yuetong Xu, Yuetong Xu, Puli Zhang, Puli Zhang, Hongxia Yang, Hongxia Yang, Qinglin Peng, Guochun Wang, Guochun Wang, Xiaoming Shu   +13 more
doaj   +1 more source

Resistin Expression Is Associated With Interstitial Lung Disease in Dermatomyositis

Frontiers in Medicine, 2022
ObjectiveIn the current study, we aimed to assess resistin mRNA levels in the peripheral blood mononuclear cells (PBMCs) of dermatomyositis patients with interstitial lung disease (DM-ILD) and their correlation with disease activity.MethodsWe detected ...
Lifang Ye, Lifang Ye, Yu Zuo, Fang Chen, Yuetong Xu, Yuetong Xu, Puli Zhang, Puli Zhang, Hongxia Yang, Hongxia Yang, Sang Lin, Sang Lin, Qinglin Peng, Guochun Wang, Guochun Wang, Xiaoming Shu   +15 more
doaj   +1 more source

Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis

Annals of the Rheumatic Diseases, 2022
Objectives Inflammatory myopathy or myositis is a heterogeneous family of immune-mediated diseases including dermatomyositis (DM), antisynthetase syndrome (AS), immune-mediated necrotising myopathy (IMNM) and inclusion body myositis (IBM).
I. Pinal-Fernández, Á. Quintana, J. Milisenda, M. Casal-Domínguez, Sandra Muñoz-Braceras, A. Derfoul, J. Torres-Ruiz, K. Pak, S. Del Orso, Faiza Naz, G. Gutierrez-Cruz, M. Milone, Shahar Shelly, Yaiza Duque-Jaimez, Ester Tobías-Baraja, A. Matas-García, G. Garrabou, Joan Padrosa, J. Ros, E. Trallero-Araguás, B. Walitt, L. Christopher‐Stine, T. Lloyd, Chen Zhao, S. Swift, A. Rajan, Josep Maria Salanova Grau, A. Selva-O’Callaghan, T. Liewluck, A. Mammen   +29 more
semanticscholar   +1 more source

Interstitial lung disease is not rare in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies

BMC Pulmonary Medicine, 2022
Objectives The purpose was to clarify the characteristics of interstitial lung disease (ILD) in immune-mediated necrotizing myopathy (IMNM) patients with anti-signal recognition particle (SRP) antibodies.
Yongpeng Ge, Hanbo Yang, Xinyue Xiao, Lin Liang, Xin Lu, Guochun Wang   +5 more
doaj   +1 more source

Immune Checkpoint Inhibitor-Related Myositis Overlapping With Myocarditis: An Institutional Case Series and a Systematic Review of Literature

Frontiers in Pharmacology, 2022
Background: Immune checkpoint inhibitor (ICI)-related myositis with myocarditis is a rare but potentially fatal immune-related adverse event. However, its clinical features, response to immunosuppressive treatment, and prognosis remain poorly understood.
Yuki Nakagomi, K. Tajiri, S. Shimada, Siqi Li, Keiko Inoue, Y. Murakata, M. Murata, S. Sakai, Kimi Sato, M. Ieda   +9 more
semanticscholar   +1 more source

Myositis Ossificans [PDF]

Western Journal of Emergency Medicine, 2011
[West J Emerg Med. 2011;12(4):371.]
Chuah, Tyng Yu, Loh, Tze Ping, Loi, Hoi Yin, Lee, Keat Hwa   +3 more
openaire   +5 more sources

Rheumatoid Myositis: A Rare Case Report [PDF]

Journal of Clinical and Diagnostic Research, 2023
Rheumatoid Arthritis (RA) and inflammatory myositis are distinct clinical syndromes. Muscle involvement in RA is frequently secondary to therapy with steroids or immune-modulators medication.
Satish Kumar, Santosh Kumar Singh, Yashas Saipangallu   +2 more
doaj   +1 more source

The myokine GDF-15 is a potential biomarker for myositis and associates with the protein aggregates of sporadic inclusion body myositis. [PDF]

, 2020
Background: The cytokine growth differentiation factor-15 (GDF-15) has been associated with inflammatory and mitochondrial disease, warranting exploration of its expression in myositis patients.
De Bleecker, Jan, De Paepe, Boel, Verhamme, Fien   +2 more
core   +2 more sources